Continental concerted efforts to control the seventh outbreak of Ebola Virus disease in Uganda: The first 90 days of the response
Accepted: 14 August 2023
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
On 20th September 2022, Uganda declared the 7th outbreak of Ebola virus disease (EVD) caused by the Sudan Ebola strain following the confirmation of a case admitted at Mubende Regional Referral Hospital. Upon confirmation, the Government of Uganda immediately activated the national incident management system to initiate response activities. Additionally, a multi‑country emergency stakeholder meeting was held in Kampala; convening Ministers of Health from neighbouring Member States to undertake cross‑border preparedness and response actions. The outbreak spanned 69 days and recorded 164 cases (142 confirmed, 22 probable), 87 recoveries and 77 deaths (case fatality ratio of 47%). Nine out of 136 districts were affected with transmission taking place in 5 districts but spilling over in 4 districts without secondary transmission. As part of the response, the Government galvanised robust community mobilisation and initiated assessment of medical counter measures including therapeutics, new diagnostics and vaccines. This paper highlights the response actions that contributed to the containment of this outbreak in addition to the challenges faced with a special focus on key recommendations for better control of future outbreaks.
Rugarabamu S, Mboera L, Rweyemamu M, Mwanyika G, Lutwama J, Paweska J and Misinzo G: Forty‑two years of responding to Ebola virus outbreaks in Sub‑Saharan Africa: A review. BMJ Glob Health 5: e001955, 2020.
Awah PK, Boock AU and Kum KA: Ebola virus diseases in Africa: A commentary on its history, local and global context. Pan Afr Med J 22 (Suppl 1): S18, 2015.
Muyembe‑Tamfum JJ, Mulangu S, Masumu J, Kayembe JM, Kemp A and Paweska JT: Ebola virus outbreaks in Africa: Past and present. Onderstepoort J Vet Res 79: 451, 2012.
History of Ebola Virus Disease (EVD) Outbreaks|History|Ebola (Ebola Virus Disease)|CDC [Internet]. 2022 [cited 2022 Dec 2]. Available from: https://www.cdc.gov/vhf/ebola/history/chronology.html.
Ebola virus disease|Nature Reviews Disease Primers [Internet]. [cited 2022 Nov 6]. Available from: https://www.nature.com/articles/s41572‑020‑0147‑3.
Kayiwa J, Kasule J, Ario A, Sendagire S, Homsy J, Lubwama B, Aliddeki D, Kagirita A, Komakech I, Brown V, et al: Conducting the Joint external evaluation in Uganda: The process and lessons learned. Health Secur 17: 174‑180, 2019.
JEE_2021 Report on the 2021 Uganda Multi‑Sectoral Self‑Assessment and Operational Planning [Internet]. [cited 2023 Feb 17]. Available from: https://www.cphl.go.ug/sites/default/files/2022-07/JEE_2021%20Uganda%20Mult-sectoral%20Self-Assessment%20Report_26Oct2021%20%282%29%20%281%29.pdf.
Li YH and Chen SP: Evolutionary history of Ebola virus. Epidemiol Infect 142: 1138‑1145, 2014.
The National Policy for Disaster Preparedness and Management|United Nations Development Programme [Internet]. [cited 2022 Nov 17]. Available from: https://www.undp.org/uganda/publications/national‑policy‑disaster‑preparedness‑and‑management.
Borchert JN, Tappero JW, Downing R, Shoemaker T, Behumbiize P, Aceng J, Makumbi I, Dahlke M, Jarrar B, Lozano B, et al: Rapidly building global health security capacity‑Uganda demonstration project, 2013. MMWR Morb Mortal Wkly Rep 63: 73‑76, 2014.
Alonso PL: The role of mass drug administration of Antimalarials. Am J Trop Med Hyg 103 (2 Suppl): 1‑2, 2020.
Shoemaker T, MacNeil A, Balinandi S, Campbell S, Wamala JF, McMullan LK, Downing R, Lutwama J, Mbidde E, Ströher U, et al: Reemerging Sudan Ebola virus disease in Uganda, 2011. Emerg Infect Dis 18(9):1480‑3, 2012.
Albariño CG, Shoemaker T, Khristova ML, Wamala JF, Muyembe JJ, Balinandi S, Tumusiime A, Campbell S, Cannon D, Gibbons A, et al: Genomic analysis of filoviruses associated with four viral hemorrhagic fever outbreaks in Uganda and the Democratic Republic of the Congo in 2012. Virology 442:97‑100, 2013.
Sudan Ebolavirus‑Experts deliberations. Candidate treatments prioritization and trial design discussions [Internet]. [cited 2023 May 18]. Available from: https://www.who.int/publications/m/item/sudan‑ebolavirus‑experts‑deliberations‑candidate-treatmentsprioritization‑and‑trial‑design‑discussions.
Edwards HM, Counihan H, Bonnington C, Achan J, Hamade P and Tibenderana JK: The impact of malaria coinfection on Ebola virus disease outcomes: A systematic review and meta‑analysis. PLoS One 16: e0251101, 2021.
World Health Organization. Mass drug administration for falciparum malaria: A practical field manual [Internet]. Geneva, World Health Organization, 2017. Available from: https://apps.who.int/iris/handle/10665/259367.
Nyenswah T, Fahnbulleh M, Massaquoi M, Nagbe T, Bawo L, Falla JD, Kohar H, Gasasira A, Nabeth P, Yett S, et al: Ebola epidemic‑Liberia, March‑October 2014. Morb Mortal Wkly Rep 63: 1082‑1086, 2014.
Fallah MP, Skrip LA and Enders J: Preventing rural to urban spread of Ebola: Lessons from Liberia. Lancet 392: 279‑280, 2018.
de St Maurice A, Ervin E, Orone R, Choi M, Dokubo EK, Rollin PE, Nichol ST, Williams D, Brown J, Sacra R, et al: Care of Ebola survivors and factors associated with clinical Sequelae‑Monrovia, Liberia. Open Forum Infect Dis 5: ofy239, 2018.
Tiffany A, Vetter P, Mattia J, Dayer JA, Bartsch M, Kasztura M, Sterk E, Tijerino AM, Kaiser L and Ciglenecki I: Ebola virus disease complications as experienced by survivors in sierra Leone. Clin Infect Dis 62: 1360‑1366, 2016.
Shrivastava SR, Shrivastava PS and Ramasamy J: Ebola disease: Infection prevention and control in hospital and community settings. Iran J Nurs Midwifery Res 20: 526‑527, 2015.
Okello G, Izudi J, Teguzirigwa S, Kakinda A and Van Hal G: Findings of a Cross‑sectional survey on knowledge, attitudes, and practices about COVID‑19 in Uganda: Implications for public health prevention and control measures. Biomed Res Int 2020:5917378, 2020.
Supporting AgenciesUganda Ministry of Health, Africa Centres for Disease Control and Prevention, Makerere University Institute of Infectious Diseases
Copyright (c) 2023 the Authors
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.